Secretome Therapeutics
Jeff Masten, MBA, has extensive experience in the biotechnology and pharmaceutical industry, serving in various leadership roles focused on operations and quality. At Secretome Therapeutics, Jeff holds the position of Senior Vice President CMC Operations. Prior to this, Jeff was the Chief Operating Officer at Theragent Inc., and Vice President and Quality Site Head at Juno Therapeutics, Inc. Additionally, Jeff served as Vice President of Technical Operations/Manufacturing at Atara Biotherapeutics and has worked as a consultant in the biotechnology and pharmaceutical industry.
This person is not in any teams
This person is not in any offices
Secretome Therapeutics
secretome Therapeutics is developing a pipeline of secretome products to address diseases driven by inflammation and mitochondrial dysfunction.